SouthState Bank Corp decreased its holdings in Microsoft Corporation (NASDAQ:MSFT - Free Report) by 5.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 256,692 shares of the software giant's stock after selling 13,600 shares during the period. Microsoft accounts for approximately 6.1% of SouthState Bank Corp'...
SouthState Bank Corp decreased its holdings in Microsoft Corporation (NASDAQ:MSFT - Free Report) by 5.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 256,692 shares of the software giant's stock after selling 13,600 shares during the period. Microsoft accounts for approximately 6.1% of SouthState Bank Corp's holdings, making the stock its biggest holding. SouthState Bank Corp's holdings in Microsoft were worth $132,954,000 as of its most recent SEC filing. Get Microsoft alerts: Sign Up A number of other hedge funds have also bought and sold shares of MSFT. Horizon Investment Services LLC lifted its holdings in shares of Microsoft by 1.6% in the 3rd quarter. Horizon Investment Services LLC now owns 20,335 shares of the software giant's stock worth $10,533,000 after buying an additional 324 shares during the period. Triglav Investments D.O.O. increased its position in shares of Microsoft by 2.7% during the third quarter. Triglav Investments D.O.O. now owns 250,101 shares of the software giant's stock worth $129,540,000 after purchasing an additional 6,496 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S boosted its holdings in Microsoft by 15.3% in the third quarter. BI Asset Management Fondsmaeglerselskab A S now owns 1,384,355 shares of the software giant's stock worth $706,461,000 after acquiring an additional 183,549 shares in the last quarter. SBI Securities Co. Ltd. grew its position in Microsoft by 1.0% during the 3rd quarter. SBI Securities Co. Ltd. now owns 201,663 shares of the software giant's stock worth $104,451,000 after purchasing an additional 1,928 shares during the last quarter. Finally, Gallacher Capital Management LLC lifted its position in Microsoft by 17.0% during the 3rd quarter. Gallacher Capital Management LLC now owns 2,927 shares of the software giant's stock worth $1,516,000 after acquiring an additional 425 shares during the p...
Triglav Investments D.O.O. increased its position in Microsoft Corporation (NASDAQ:MSFT - Free Report) by 2.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 250,101 shares of the software giant's stock after buying an additional 6,496 shares during the period. Microsoft accounts for about 8.5% of...
Triglav Investments D.O.O. increased its position in Microsoft Corporation (NASDAQ:MSFT - Free Report) by 2.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 250,101 shares of the software giant's stock after buying an additional 6,496 shares during the period. Microsoft accounts for about 8.5% of Triglav Investments D.O.O.'s investment portfolio, making the stock its 2nd biggest position. Triglav Investments D.O.O.'s holdings in Microsoft were worth $129,540,000 at the end of the most recent reporting period. Get Microsoft alerts: Sign Up Several other institutional investors have also added to or reduced their stakes in MSFT. IRON Financial LLC raised its stake in Microsoft by 23.2% in the third quarter. IRON Financial LLC now owns 6,510 shares of the software giant's stock worth $3,372,000 after buying an additional 1,225 shares in the last quarter. Wellington Capital Management Inc. purchased a new position in shares of Microsoft in the 2nd quarter valued at $9,941,000. Sound View Wealth Advisors Group LLC raised its position in shares of Microsoft by 2.6% in the 2nd quarter. Sound View Wealth Advisors Group LLC now owns 94,120 shares of the software giant's stock worth $46,816,000 after acquiring an additional 2,373 shares in the last quarter. Trifecta Capital Advisors LLC lifted its stake in shares of Microsoft by 2.3% during the 3rd quarter. Trifecta Capital Advisors LLC now owns 70,175 shares of the software giant's stock worth $36,347,000 after purchasing an additional 1,572 shares during the last quarter. Finally, Weaver Capital Management LLC boosted its position in Microsoft by 14.0% during the third quarter. Weaver Capital Management LLC now owns 18,340 shares of the software giant's stock valued at $9,499,000 after purchasing an additional 2,247 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company's stock....
Triglav Investments D.O.O. grew its holdings in Apple Inc. (NASDAQ:AAPL - Free Report) by 10.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 353,707 shares of the iPhone maker's stock after acquiring an additional 34,306 shares during the quarter. Apple accounts for 5.9% of Triglav Investments D.O.O.'s portfolio, making the...
Triglav Investments D.O.O. grew its holdings in Apple Inc. (NASDAQ:AAPL - Free Report) by 10.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 353,707 shares of the iPhone maker's stock after acquiring an additional 34,306 shares during the quarter. Apple accounts for 5.9% of Triglav Investments D.O.O.'s portfolio, making the stock its 3rd largest holding. Triglav Investments D.O.O.'s holdings in Apple were worth $90,063,000 as of its most recent SEC filing. Get Apple alerts: Sign Up Several other large investors have also recently bought and sold shares of AAPL. Sellwood Investment Partners LLC increased its holdings in Apple by 110.9% in the 3rd quarter. Sellwood Investment Partners LLC now owns 135 shares of the iPhone maker's stock valued at $34,000 after buying an additional 71 shares during the period. ROSS JOHNSON & Associates LLC lifted its stake in Apple by 1,800.0% during the first quarter. ROSS JOHNSON & Associates LLC now owns 190 shares of the iPhone maker's stock worth $42,000 after purchasing an additional 180 shares during the period. Nexus Investment Management ULC boosted its holdings in Apple by 333.3% during the second quarter. Nexus Investment Management ULC now owns 260 shares of the iPhone maker's stock valued at $53,000 after purchasing an additional 200 shares in the last quarter. LSV Asset Management bought a new stake in shares of Apple in the 4th quarter valued at approximately $65,000. Finally, Morgan Dempsey Capital Management LLC lifted its position in shares of Apple by 41.0% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 430 shares of the iPhone maker's stock worth $88,000 after buying an additional 125 shares during the period. 67.73% of the stock is currently owned by institutional investors and hedge funds. Apple Stock Down 0.5% Shares of NASDAQ AAPL opened at $262.52 on Thursday. The firm has a 50 day moving average price of $264.14 a...
Shares of Eli Lilly and Company LLY have declined 5.2% in the past month despite the company reporting robust fourth-quarter 2025 results on Feb. 4. Industry pricing concerns, rising competitive pressure in the diabetes and obesity market and broader equity market corrections have led to downward pressure on shares. Rival Novo Nordisk NVO recently cut prices of its semaglutide medicines, Ozempic f...
Shares of Eli Lilly and Company LLY have declined 5.2% in the past month despite the company reporting robust fourth-quarter 2025 results on Feb. 4. Industry pricing concerns, rising competitive pressure in the diabetes and obesity market and broader equity market corrections have led to downward pressure on shares. Rival Novo Nordisk NVO recently cut prices of its semaglutide medicines, Ozempic for diabetes and Wegovy for obesity. The price cuts by NVO triggered investor concerns that Lilly may also need to cut prices of its widely used GLP-1 therapies, Mounjaro, for type II diabetes, and Zepbound for obesity. There are also some concerns that the global obesity market may not be as large as the previous expectation of around $150 billion due to pricing and competitive pressures. The drop in Lilly’s share price occurred after a very strong rally earlier, following the robust Q4 results and an optimistic guidance for 2026. So, should this be treated as a buying opportunity or a warning sign to stay away from the stock for now? To make the investment decision, let us understand the company’s strengths and weaknesses. Strong Growth of LLY’s GLP-1 Drugs Mounjaro and Zepbound Lilly boasts a robust portfolio of treatments for diabetes and other cardiometabolic conditions, with its cardiometabolic division emerging as the company’s strongest segment. This success is largely attributed to strong sales of Mounjaro and Zepbound. Despite being on the market for slightly more than three years, Mounjaro and Zepbound have become key top-line drivers for Lilly, with demand rising rapidly. These therapies account for more than 50% of the company’s total revenues. Mounjaro is the market leader in new prescriptions within type II diabetes incretin analogs in both the United States and ex-U.S. markets, while Zepbound also holds a leading market share in the branded obesity market with nearly 70% share of new prescriptions. In 2025, the drugs generated combined sales of $36.5 billion,...
US futures were pointing to a softer open on Wall Street on Thursday, after Iran de-escalation hopes earlier boosted European markets before being played down. Dow Jones futures were down 0.5%, with the S&P 500 and the Nasdaq both slipping 0.2%. A day earlier, US stocks closed solidly...
US futures were pointing to a softer open on Wall Street on Thursday, after Iran de-escalation hopes earlier boosted European markets before being played down. Dow Jones futures were down 0.5%, with the S&P 500 and the Nasdaq both slipping 0.2%. A day earlier, US stocks closed solidly...
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity". Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. That said, here are two profitable companies that balan...
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity". Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. That said, here are two profitable companies that balance growth and profitability and one that may struggle to keep up. One Stock to Sell: LeMaitre (LMAT) Trailing 12-Month GAAP Operating Margin: 25.9% Founded in 1983 and named after a pioneering vascular surgeon, LeMaitre Vascular (NASDAQGM:LMAT) develops and manufactures specialized medical devices used by vascular surgeons to treat peripheral vascular disease and other circulatory conditions. Why Are We Hesitant About LMAT? Smaller revenue base of $249.6 million means it hasn’t achieved the economies of scale that some industry juggernauts enjoy At $106.58 per share, LeMaitre trades at 37.9x forward P/E. If you’re considering LMAT for your portfolio, see our FREE research report to learn more. Two Stocks to Buy: Broadcom (AVGO) Trailing 12-Month GAAP Operating Margin: 40.7% Originally the semiconductor division of Hewlett Packard, Broadcom (NASDAQ:AVGO) is a semiconductor conglomerate spanning wireless communications, networking, and data storage as well as infrastructure software focused on mainframes and cybersecurity. Why Is AVGO a Top Pick? Annual revenue growth of 32.5% over the last two years was superb and indicates its market share increased during this cycle Offerings are mission-critical for businesses and lead to a best-in-class gross margin of 75.3% AVGO is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders Broadcom’s stock price of $334.30 implies a valuation ratio of 26.1x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free. American Superconductor (AMSC) T...
Abram81/iStock via Getty Images A world at war. The United States and Israel are hammering the Iranian regime, and Iran has been lashing out at American assets and allies across the Middle East. Already, some experts are warning that the United States and its allies could run out of interceptors, which have proven crucial for countering Iran’s ballistic missiles. Before the dust even settles, you ...
Abram81/iStock via Getty Images A world at war. The United States and Israel are hammering the Iranian regime, and Iran has been lashing out at American assets and allies across the Middle East. Already, some experts are warning that the United States and its allies could run out of interceptors, which have proven crucial for countering Iran’s ballistic missiles. Before the dust even settles, you can expect the United States to begin replenishing its ordnance, and the effectiveness of drones on the battlefield will likely drive America to up the ante, buying new hardware and expanding capabilities. Against this backdrop, the First Trust Indxx Aerospace & Defense ETF ( MISL ) and Global X Defense Tech ETF ( SHLD ) both look like attractive stocks. I’ve been a proponent of SHLD for quite some time now, and while I still think it is a good ETF, as far as the Iran war and my rearmament theory go, MISL is the better bet, as it’s US-concentrated, while SHLD is globally focused. Thus, I’m ranking MISL a buy and SHLD a hold. America Will Need To Replenish Its Weapons and Interceptor Stocks The United States has been carrying out devastating strikes against the Iranian government. As of yesterday, CENTCOM has claimed that it has struck over 2,000 targets, and since then, attacks appear to be ramping up. Israel, too, has carried out hundreds (and probably a thousand-plus by now) of strikes. The American government, unsurprisingly, is rather mum when it comes to weapon stockpiles and how many specific weapons have been expended. A Heritage Foundation analyst reports that “Through 2023, the U.S. has procured roughly 12,000 Standard Missile-2s (SM-2), 400 Standard Missile-3s (SM-3), 1,500 Standard Missile-6s (SM-6), and 9,000 Tomahawk Land Attack Missiles (TLAM)—the principal VLS-launched weapons.” The report also notes, “Over that same time, it has expended at least 2,800 Standard Missiles and 2,900 TLAMs, leaving the U.S. with on-paper maximums of roughly 11,000 missiles in th...
Berkshire Hathaway ( BRK.A ) ( BRK.B ) is repurchasing shares of its class A and class B common stock under the company's long-standing share repurchase policy. Under the policy, the company buys back shares when they believe the repurchase price is below the intrinsic value, conservatively determined. BRK.B was trading 1.72% higher at $495.85 on Thursday before the U.S. market open. The company s...
Berkshire Hathaway ( BRK.A ) ( BRK.B ) is repurchasing shares of its class A and class B common stock under the company's long-standing share repurchase policy. Under the policy, the company buys back shares when they believe the repurchase price is below the intrinsic value, conservatively determined. BRK.B was trading 1.72% higher at $495.85 on Thursday before the U.S. market open. The company said its policy does not obligate it to acquire any specific number of shares. Shares may be bought in the open market or in privately-negotiated transactions, with the timing and amount of repurchases depending on the market prices of the stocks and market conditions, among other factors. Berkshire Hathaway said the buybacks may be discontinued at any time without prior notice, and the company does not undertake any obligation to update or revise any disclosures. Additionally, the company reported that CEO Greg Abel has bought shares worth $15.3M. The CEO's trust, Gregory E. Abel Revocable Trust, acquired 4,301 class A shares of indirect ownership on Wednesday, a separate filing by the company showed. Each class A share is convertible at any time into 1,500 shares of class B shares, the filing noted. Last, Berkshire Hathaway repurchased shares of its own in May 2024, CNBC News noted. Normally, the company wouldn't disclose the start of the repurchases. "We felt it was important to communicate to our shareholders, our partners, our owners, with the transition of leadership," Abel told CNBC in an interview . More on Berkshire Hathaway Inc. Would Warren Buffett Buy Berkshire Today? Berkshire Hathaway's Handoff Year: Buffett's Final Lessons, Abel's First Blueprint Berkshire Hathaway Is A Hedge For AI Bubbles Berkshire Hathaway shares slip after Q4 earnings, Abel's letter Greg Abel stresses Berkshire Hathaway's prudent approach to its businesses in annual letter
Ciena (CIEN) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 77.78%. A quarter ago, it was expected that this developer of high-speed networking technology would post earni...
Ciena (CIEN) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 77.78%. A quarter ago, it was expected that this developer of high-speed networking technology would post earnings of $0.08 per share when it actually produced earnings of $0.61, delivering a surprise of 662.50%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Ciena , which belongs to the Zacks Fiber Optics industry, posted revenues of $1.06 billion for the quarter ended January 2023, surpassing the Zacks Consensus Estimate by 10.14%. This compares to year-ago revenues of $844.44 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Ciena shares have lost about 3.7% since the beginning of the year versus the S&P 500's gain of 5.4%. What's Next for Ciena? While Ciena has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead o...
(RTTNews) - Hongkong Land Holdings (SGX) reported fiscal 2025 profit attributable to shareholders of $1.26 billion compared to a loss of $1.39 billion, prior year. Profit per share, in cent, was 57.85 compared to a loss of 62.76. Underlying profit attributable to shareholders was $458 million, down 8%. Underlying earnings per share, in cent, was 20.98 compared to 22.60. For the year ended 31 Decem...
(RTTNews) - Hongkong Land Holdings (SGX) reported fiscal 2025 profit attributable to shareholders of $1.26 billion compared to a loss of $1.39 billion, prior year. Profit per share, in cent, was 57.85 compared to a loss of 62.76. Underlying profit attributable to shareholders was $458 million, down 8%. Underlying earnings per share, in cent, was 20.98 compared to 22.60. For the year ended 31 December 2025, total revenue declined to $1.45 billion from $2.00 billion, previous year. Underlying revenue was $1.05 billion compared to $1.09 billion. Hongkong Land shares on Frankfurt are trading at 6.95 euros, up 1.46%. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.